Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Treatment Efficacy
Interventions: DRUG: HX008，Niraparib|DRUG: HX008，Niraparib|DRUG: HX008，Niraparib，Trastuzumab|DRUG: HX008，Niraparib，Pyrrolitinib
Sponsor: Fudan University